Bromo-DragonFLY is a substance related to the phenethylamine family.
| FactSnippet No. 624,711 |
Bromo-DragonFLY is a substance related to the phenethylamine family.
| FactSnippet No. 624,711 |
Bromo-DragonFLY is considered a potent hallucinogen, having around one third the potency of LSD with a normal dose in the region of 200 µg to 800 µg, and it has an extremely long duration of action, up to several days.
| FactSnippet No. 624,712 |
Bromo-DragonFLY has a stereocenter and-(-)-bromo-DragonFLY is the more active stereoisomer.
| FactSnippet No. 624,713 |
Bromo-DragonFLY was first synthesized by Matthew Parker in the laboratory of David E Nichols in 1998.
| FactSnippet No. 624,714 |
Bromo-DragonFLY is a MAO-A inhibitor, and thus strongly inhibits oxidative deamination of 5-HT, increasing its risk profile.
| FactSnippet No. 624,715 |
The 1998 synthesis of racemic Bromo-DragonFLY starts from hydroquinone, which is dialkylated with 1-bromo-2-chloroethane, brominated, and treated with n-butyllithium to yield the tetrahydrobenzodifuran ring system.
| FactSnippet No. 624,716 |
In 2001, David E Nichols reported an enantiospecific synthesis of Bromo-DragonFLY which allowed the individual R and S enantiomers to be studied.
| FactSnippet No. 624,717 |
Toxicity of Bromo-DragonFLY appears to be fairly high for humans, with reports of at least five deaths believed to have resulted from Bromo-DragonFLY in Norway, Sweden, Denmark, Finlandand the United States.
| FactSnippet No. 624,718 |
Vasoconstrictive action resulting from severe overdose of Bromo-DragonFLY is known to have caused tissue necrosis of the extremities in at least one case.
| FactSnippet No. 624,719 |
Bromo-DragonFLY's friend described the trip saying, "It was like being dragged to hell and back again.
| FactSnippet No. 624,720 |
Bromo-DragonFLY is unscheduled at federal level in the United States but could be persecuted if it sold for human consumption, Bromo Dragonfly is listed as a Schedule I in Oklahoma.
| FactSnippet No. 624,721 |
Bromo-DragonFLY is widely reported by the media as being a Class A drug.
| FactSnippet No. 624,722 |
Bromo-DragonFLY was first classified as "health hazard" by Sveriges riksdags health ministry Statens folkh institut under the act Lagen om forbud mot vissa h farliga varor as of Jul 15, 2007, in their regulation SFS 2007:600 listed as brombensodifuranylisopropylamin (Bromo-Dragonfly), making it illegal to sell, purchase, buy, retail or possess.
| FactSnippet No. 624,723 |